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Previous studies of isolated human antibodies have revealed relative homo- 
geneity when compared with whole -y-globulin of the donor. Such isolated anti- 
bodies may be  of  a  single  class  ('yG,  3,M, or  ~/A) and  may  show  a  pre- 
dominance of a single light chain type (kappa or lambda) (1).  They may show 
selective exclusion  or predominance  of individual  Gm or Inv genetic factors 
present in donor sera (2), and may show relatively more homogeneity of elec- 
trophoretic mobility of isolated chains  as compared  to whole T-globulin  (3). 
Human ~/G-immunoglobulin  has been shown to contain four subgroups based 
on antigenic differences  in the heavy polypeptide chains  (4-6).  Approximate 
percentages of normal 3'G  and frequency of occurrence of myeloma proteins 
of each subgroup are: ~,G1--55 %, ~/G2--23 To, ,yG3---8 % (7), and -yG4--4%.  1 
It  has  been  shown  that  individual  Gin  genetic  antigens  are  found  only in 
molecules of a single subgroup (8, 9). With the recent addition of Gin(n)  as a 
genetic marker for the majority of 7G2-molecules (10) and Gin(g)  as an allele 
for  Gin(b)  among  5,G3-molecules  (11),  virtually  all  3,G-molecules  may  be 
positively identified by heavy chain subgroup and more than 85 % by genotype. 
Immunization  with  dextran,  levan,  and  blood group  substances has  been 
shown  to elicit antibody responses which  may persist  for many years  (12). 
Previous  studies  have  demonstrated  that  isolated  anti-dextrans  are  usually 
heterogeneous  as to  class  of  immunoglobulin  (2)  light  chain  type  (1),  and 
in  amino  acid  composition  (13,  14).  In  addition,  heterogeneity of antibody 
specificity for the type of linkage of the repeating glucosyl units  (15-17)  and 
* Aided by grants from the Public Health Service (AM 09792-03),  the National Science 
Foundation (GB 3675), and the General Research Support Grant of the United States Public 
Health Service. 
1 The nomenclature used for the heavy chain subgroups of "),G-globulins are those recently 
adopted by a subcommittee of the World Health Organization: 3'G1  (We or 3'~b); 3'G2 (Ne 
or "yu); 3'G3 (Vi or "y~); 3'G4 (Ge or 3'2d). 
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heterogeneity of combining site size,  based  on variable affinity for oligosac- 
charides of the isomaltose series, have been demonstrated (18-20). 
The subfractionation of anti-dextran based on these variations in specificity 
(19,  20)  offers a possible means  of  obtaining more homogeneous antibodies. 
This report summarizes the quantitative characterization of several such anti- 
bodies as to heavy chain subgroup, genotype, and light chain type. The find- 
ings indicate that some isolated antibodies, or purified subfractions, may be 
very homogeneous and consist of a  single heavy chain subgroup, contain Gm 
antigens from only one of two alternative alleles,  and contain antigens of a 
single light chain type. They thus closely resemble myeloma proteins. 
TABLE  I 
Type of Dextran  Used for Immunization and Glycosidic Specificity  o/Human  Anti-Oextrans 
Studied (15"17) 
Subject  Dextran used for  immunization  Specificities  for  glycosidic  linkage 
1 
20 
J. Ge. 
Fo. 
R.G.M. 
333 
332 
30 
Native dextran B 1255 
Clinical Swedish dextran OP155 
Native dextran B512 
NRRL* B512 
NRRL B1424 
NRRL B1299 S-3 
NRRL B1299 S-3 
NRRL B512 
a-(1 --~ 6) 
a-(1 --* 6) 
a-(1 ~  6) 
a-(1 ~  6) 
a-(1 ~  6) +  a-(1 ~  2) 
a-(1 --~ 6)  +  a-(1 ~  2) 
a-(l ~  6)  +  a-(1 -+ 2) 
a-(1 --~ 6) 
* NRRL, Northern Regional Research Laboratory, now called Northern Regional  Utili- 
zation Laboratory,  U. S. Department of Agriculture, Peoria,  Ill. 
Materials and Methods 
45 fractions of isolated antibodies from 13 normal persons were prepared and of these 34 
were in sufficient concentration for study in multiple systems. 
Human Antisera.--Anfi-dextrans or subfractions from eight donors were studied (Table I). 
Varying antibody speciticities related  to  type of  glucosyl  linkage  (15-17)  were  obtained, 
depending upon the dextran preparation used for immunization. Teichoic acid  antibodies 
from these and one additional donor  (Da)  immunized with teichoic acid  Copenhagen (21) 
were  also  studied.  Four  persons were  immunized with porcine blood  group  A  substance 
(Ortho 63-2622,  Wh, R.G., 6460). Antibodies to dextran, levan, diphtheria toxoid, and alum- 
precipitated tetanus toxoid were obtained from a single individual (subject 1)  (13). 
Isolation and Preparation of Antibody.--Sera  were cleared by prolonged centrifugation at 
4°C.  Antibodies to teichoic acid,  diphtheria toxoid,  tetanus toxoid,  and A  substance were 
allowed to  precipitate for 7  days with respective antigens at  the point of  maximum pre- 
cipitation, as determined previously by quantitative precipitin curves (22). Precipitates were 
washed three times in cold phosphate-buffered saline, pH 7.2. Washed antigen-antibody pre- 
cipitates of teichoic acid, diphtheria toxoid, A substance, and tetanus toxoid were dissolved 
in excess of the respective antigen. The sequential precipitation of a-(1 --~ 6)- andes-(1 ~  2)- 
specific anti-dextrans from subjects 332,  333,  and R.G.M.  has been described in detail pre- 
viously (14,  16).  Dextran-anfi-dextran precipitates with c~-(1 --~ 6)  specificity were treated 
with dextranase (23),  while the subsequent a-(1 --~ 2)-specific precipitates were dissolved in W. J. YOUNT~ x~. ~r. DORNER~ H. G. KUNKEL, E. A. KABAT  635 
antigen excess. Residual precipitates were partially dissolved by the addition of 1 ~  acetate 
buffer, pH 3.8, for 1 hr at 37°C and then supernatants were analyzed. Oligosaccharides of the 
isomaltose series were used to elute antibodies preferentially on the basis of heterogeneity in 
size of combining site (20). In subject 1, an isomaltohexaose (IM6) elutionwas followed by an 
isomaltotriose (IM3)  elution with 60% total recovery of antibody nitrogen.  In subject 20, 
the reverse order of elution was carried out and  antibody recovery was 62%.  In subjects 
20 and J.  Ge., sequential  elution of anti-dextran  using oligosaccharides of increasing  size 
[glucose, methyl-o~-D-glucoside, and  isomaltose (IM2)  to isomaltohexaose (IM6)] was carried 
out. The first two elutions (glucose and methyl-~-D-glucoside) represented 28% yield of total 
antibody nitrogen in subject 20,  and 42% in subject ].  Ge. Purified anti-levan of subject 1 
was obtained by absorption on levan gel and elution of the antibody. For removal of a total 
of 816/~g of anti-levan nitrogen in 204 ml of serum from subject 1, 50 mg of levan gel were 
packed into a  co],mn. After the serum had  been passed  through the column, quantitative 
precipitation showed removal of anti-levan. Antibody was eluted from the column with 0.1 
sodium acetate buffer, pH 3.8,  and  the fractions containing eluted antibody were pooled, 
concentrated by ultrafiltration, and dialyzed versus phosphate-buffered saline, pH 7.2. Total 
antibody recovery was 61%. 
Myeloma  and  Macroglobulin Protdns.--Putified  immunoglobulins  were  prepared  from 
patients with an established diagnosis of multiple myeloma or maeroglobulinemia. Proteins 
were isolated  and  heavy or light chains  or enzymatic digestion fragments  were prepared 
as previously described (7). 
Antisera.--Antisera  specific  for "yG-, TA-, 3'M-, kappa,  lambda,  "yG-heavy chain sub- 
groups,  and genetic factors were prepared by the immunization of rabbits,  cynomolgus or 
rhesus  monkeys,  or baboons  with isolated whole immunoglobulins,  polypeptide chains,  or 
enzymatic digestion fragments. The antisera were absorbed with isolated Bence Jones pro- 
teins, myeloma proteins or digestion fragments, fraction II, isolated normal 3'G or selected 
sera in order to obtain the light chain type or heavy chain class, subgroup, or Gm specificity 
sought as has been described in detail (1, 4,  7,  10, 24).  The baboon antisera were prepared 
through  the cooperation of Dr. J.  Moor-Jankowski and  the Laboratory for Experimental 
Medicine and Surgery in Primates. 
Precipitin  AnMysis.--Isolated  antibodies  were  qualitatively characterized  by  microim- 
munoelectrophoresis  or  Ouchterlony  double  diffusion.  For  semiquantitative  experiments 
serial two-fold dilutions of isolated antibody were reacted with specific  antisera in double 
diffusion in agar (1)  and compared with immunoglobulin solutions of known concentration. 
Quantitation of 7G-, TA-, TM-, kappa, lambda, TG2-, 7G3-, and TG4-subgroups was carried 
out by radial immunodiffusion (25, 26) modified as previously described for the 7G3-subgroup 
(7). The isolated immunoglobulins used as standards  were tested in high concentration  on 
radial diffusion  plates for concentrations of contaminant immunoglobulins and were found 
to contain less than i% of proteins of other classes,  subgroups, or of the opposite light chain 
type.  Protein  concentrations  of  standard  solutions  were  determined  by  the  Polin-Lowry 
technique and Kjeldahl or ninhydrin nitrogen determination (22). 
Of many antisera showing 7G-subgroup specificity, only a few were suitable for quantita- 
tive radial immunodiffusion. After absorption, these antisera showed complete fusion without 
spur  formation  with  all  myeloma  protein~ of  the  subgroup  and  with normal  sera.  They 
showed no cross-precipitation or inhibition of precipitation by proteins of other subgroups ex- 
cept as previously described for the 7G2- and 7G3-subgroups (10), and contained no antibod- 
ies to other serum proteins. The prior diffusion of known immunoglobulins of other classes and 
subgroups was  shown not to affect the precipitin ring size of standard solutions subsequently 
applied to the same test well. For each TG-subgroup quantitation, from two to seven purified 
standard  proteins of varying genetic type and light chain type were employed and gave sim- 
ilar results as did at least two different antisera for  each system. The  minimum concentra- 636  STUDIES  ON  HUMAN  ANTIBODIES.  VI 
tions of "yG-subgroup  proteins detectable were as follows: "yGI:  20-30 #g/ml; yG2:10 #g/ml; 
"yG3:20 #g/ml; 7G4:10 #g/ml. 
C,m Typing.--Gm typing was  carried out  using standard  hemagglutination-inkibition 
techniques. In addition, typing for Gin(n) and Gin(g) was carried out using precipitation 
techniques in an Ouchterlony system (7, 10). A radial diffusion system for Gm typing for 
Gin(n) and Gin(g) using 5 #1 samples of sera, isolated myeloma proteins, and some of the 
isolated antibodies was developed. Complete agreement between the microtechnique, the 
Ouchterlony precipitin technique, and  hemagglutination-inhibition techniques for Gin(n) 
and Gin(g) were shown with a panel of normal sera and isolated myeloma proteins in con- 
centrations as low as 40-50/~g/ml. A baboon antiserum made against a Gin(g+)  myeloma 
protein (7) or a monkey antiserum against Gin(n+) isolated heavy chains absorbed to yield 
desired subgroup and genetic specificity (10) were incorporated into radial diffusion plates 
prepared as previously described (7). With plates of 1 mm uniform thickness, wells 2.8 mm 
in diameter were filled  with 5 #1 Of sample. Only sera positive for these Gm antigens produced 
precipitin rings. Gin(n) typing was also carried out using human red blood cells coated with 
a Gin(n+) myeloma  protein using bis-diazotized  benzidine (27). 
RESULTS 
Quantitation of'yG--tteavy Chain Subgroups.--The chief finding of interest was 
that the anti-levan isolated from donor 1 and isolated anti-dextrans from six 
of eight  donors were composed predominantly or  exclusively of 7G2-heavy 
chains (Table II). In the table, the quantitative data by radial immunodiffu- 
sion  are  expressed as percentages of the  total antibody protein by nitrogen 
determination; the heavy chain subgroup quantitations are expressed as per- 
centages of total ~/G. For example, the quantitative values for the most ho- 
mogeneous antibody, anti-levan isolated from subject  1 were: antibody total 
protein-0.32: 7G1-0.0, 7G2-0.31, -yG3-0.00,  7G4-0.00,  total 7G-0.32, "yA-0.0, 
~M-0.0, kappa-0.30, lambda-0.00 mg/ml. All of the isolated anti-dextrans from 
subjects 1,  20,  J.Ge., and 30 and anti-dextrans of a-(1 ---> 6)  specificity from 
subjects  333  and  332  were  primarily ~/G2-subgroup  proteins.  Anti-dextran 
from subject Fo., also of a-(1 --+ 6) specificity, contained an equal mixture of 
"yG1- and -yG2-molecules. Only  in  subject  R.G.M.  were  anti-dextrans  of ~- 
(1 -~ 6) specificity composed primarily of molecules of the major or 7Gl-sub- 
group.  Anti-dextrans  of predominantly  a-(1  --*  2)  specificity from subjects 
333 and 332 were primarily 7G2, and those from donor R.G.M. were primarily 
"yG1 in parallel with the findings for the anti-dextrans of a-(1 --~ 6) specificity 
from the same individuals.  Fig.  1 illustrates the radial diffusion quantitation 
of "yG, "~,G2, ~/G3, and ~G4 for three anti-dextrans isolated as oligosaccharide 
eluates from subject 20, with each of the isolates exhibiting exclusively ~,G2- 
subgroup heavy chains.  From the sensitivity of the detection technique and 
total protein concentration, one can estimate the qtG1, "yG3, and ~'G4 content 
of many of the preparations to be less than 5 % of the total antibody protein 
despite  the  fact  that  the  mean percentage for these  three  subgroups  totals 
75-80%  of pooled "yG. For  example,  in  the  glucose eluate  of isolated  anti- 
dextran from subject 20, less than 20/1800's (sensitivity of detection vs. total TABLE  II 
Percentages  of TC--Heavy Chain Subgroups,  Classes of Immnnoglobulins, and Light Chain Types in Isolated  Human 
Antibodies as Determined by Radial Immunodiffusion  Using Specific  Antisera 
Subject 
J.Ge. 
Fo° 
R.G.M. 
333 
332 
30 
Ortho  63- 
2622 
Wb 
R.G. 
6460 
Da 
Antibody 
Dextran 
tt 
Levan 
Diphtheria  toxoid 
Tetanus 
Dextran 
Dextran 
#t 
Dextran 
Teichoic acid 
Dextran 
Teichoic acid 
Dextran 
t~ 
Teichoic acid 
Dextran 
Teichoic acid 
Dextran 
A  substance 
A substance 
A substance 
A substance 
B teichoic 
Method of 
isolation 
IM6 eluate 
IM3 eluate 
N236 ppt$ 
Acid eluate 
Ppt§ 
Ppt§ 
IM3 eluate 
IM6 eluate 
Glucose eluate 
Methyl-ot-D-glu- 
coside eluate 
OP155  ppt~ 
Glucose eluate 
Methyl-Ot-D-glu- 
coside eluate 
N236 ppt~ 
B512 ppt$ 
Pptll 
N1424 pptJ; 
N279 ppt$ 
Remaining ppt 
I1¶ 
Pptl[ 
B1299  S-3 ppU; 
N279 ppt~ 
Remaining ppt 
ll¶ 
Pptll 
B1299  S-3 ppt~ 
N279 ppt~ 
Remaining ppt 
II¶ 
Pptl] 
OP1555 
q,G-eluate§ 
Pptl] 
yG-eluate] 
PptIl 
Ppt§ 
L  chain 
type 
Per cent 
97  3 
15  85 
79  11 
100  0 
56  44 
62  38 
30  70 
68  32 
42  58 
I  11  89 
i  21  79 
19  21 
)2  8 
55  35 
75  25 
)0  0 
33  17 
28  72 
43  57 
86  14 
40  60 
20  80 
40  60 
20  80 
86  14 
36  64 
*  (),  estimated percentages. 
:~ Dextranase  eluate. 
§ Antigen  excess. 
][ Acid  eluate. 
¶  Predominate  specificity for  c¢-(1 -* 2)  linkages. 
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3'G  in  ~g/ml)  was  3'G3-subgroup,  or less than  0.8%  instead  of  the  normal 
percentage  of  8%,  a  selective  exclusion  of  this  subgroup  of  at  least  10-fold 
magnitude, The 3,G3- and 3,G4-proteins were clearly reduced below the normal 
mean  percentages  in  all  specimens  showing  a  total protein  concentration  of 
greater than 0.2 mg/ml total 3'G. 
Fro.  1.  Radial  immunodiffusion analysis of  serum and  subfractionated  anti-dextrans 
from subject 20 is shown. The oligosaccharide IM6, IM3, and methyl-a-D-glucoside  (a-CH:0 
eluates contained 3'G2 heavy chain subgroup molecules, but  lacked 7G3  and  3'G4. The 
whole serum was diluted 1  :  3.5 for analysis of 3'G2, and 1  : 10 for analysis of total 3'G. 
The predominance of 3,G2-subgroup in many of the preparations was sup- 
ported  both  by  the  inability  to  detect  3,G1-,  3'G3-, and  3,G4-molecules,  the 
agreement  between  the  antibody protein  by nitrogen  determination  and  the 
"yG and  3'G2  quantitations  by radial  immunodiffusion.  In  only  1  of  23  iso- 
lated  anti-dextrans  from  the  eight  donors could 3'G3- and 3,G4-molecules be 
detected (subject R.G.M.). 
Three  of  the  antibodies  to  teichoic  acid  (subiects  Fo.,  333,  and  332)  con- 
tained  predominantly "yG2-molecules as  well  (Table  II). Two  other  isolated 
antibodies  to  teicboic acid  contained  similar ratios  of subgroup  molecules to W.  J. ¥OUN:r, l~.  M.  DORNER, It. G. KUNKEL~  E. A. KABAT  639 
those found in whole ~/-globulin.  This was also the case for the isolated diph- 
theria  and tetanus  anti-toxins from subject  1.  Some of these antibodies were 
only available at low protein  concentrations and low concentrations of 3'G3- 
and ~G4-molecules could not be ruled out. 
Of the  four antibodies  specific  for A  substance,  "yG1 predominated  in  all, 
3'G2 was present in each in approximately the usual percentage. The identifica- 
tion of 3,Gl-molecules in one of the antibodies to A substance and lack of 3,G1 
in two anti-dextrans and one anti-levan are shown in Fig. 2. In two antibody 
preparations,  3'G3 could be  detected  (subjects  Wh.  and  6460)  but "yG4 was 
not detected. 
In most of the isolated antibodies, 3'A- and 3'M-molecules were absent or in 
concentrations of less  than  10-20%  of the  total antibody protein  (Table II). 
FIG.  2.  The characterization of isolated human antibodies for 3'Gl-subgroup molecules is 
shown. The central well contains an absorbed rabbit antiserum specific for "yG1. Wells 1 and 
2 contain IM3 eluates of anti-dextrans isolated from subjects 20 and 1; well 4 contains anti- 
levan isolated from subject 1. Well 3 contains fraction II, and well 6 an isolated 3'Gl-subgroup 
myeloma protein. Isolated antibody to A substance from subject R.G.M., shown in well 5, 
shows a complete fusion of the precipitin line with that of the 3'Gl-myeloma protein. The 
anti-dextrans and anti-levan fail to react. All materials were tested at 0.5 mg/ml protein 
concentration. 
Only the antibodies to diphtheria toxoid, the anti-dextrans  and  anti-teichoic 
acid antibodies of subjects Fo.  and 332,  and  anti-dextran  from  subject  333 
showed higher  percentages  of 3'A- or ~M-molecules.  Of interest  is  the  per- 
sistence of 3'A- and 3,M-molecules in one of the antibodies to dextran isolated 
from  subject  1  despite  an  interval  of  13  yr from  the  last  immunization  to 
collection  of  specimens  for  these  isolations.  The  shortest  intervals  between 
immunization and the collection of specimens were in subjects J.Ge., Fo., 333, 
and 332 with intervals of 6-8, 6, 3, and 8 months respectively. 
Quantitation of Light Chain Types.--Quantitation  was also carried out em- 
ploying antisera  specific  for either kappa or lambda light chain determinants 
both  by immunoprecipitation  of  serially  diluted  isolated  antibodies  and  by 
radial immunodiffusion. Two different antisera were used for each light chain 
type. Because of the predominance of "yG-molecules  in the isolated antibodies, 
purified 3,G-myeloma proteins were employed as standards. The limit of sensi- 640  STUDIES  ON  HU1VIAN ANTIBODIES.  VI 
tivity of the radial immunodiffusion quantitations was  10/zg/ml for both the 
kappa  and  lambda  systems. Marked variations in ratio  of kappa  to lambda 
were seen (Table II). At one extreme, anti-levan isolated from subject 1 con- 
tained exclusively kappa determinants, and as little as 10/320's of the isolated 
antibody should have shown detectable lambda determinants based upon sensi- 
tivity of the system for detecting lambda proteins vs.  the total/~g/ml of ~G 
present.  At  the  opposite  extreme,  the  methyl-a-D-glucoside  eluate  of  anti- 
dextran from subject 20  showed 89% lambda and  11% kappa  determinants. 
Marked variation in kappa:lambda  ratio was seen among the subfractions 
of anti-dextran. Purified anti-dextran isolated from single donors by specificity 
for  glycosidic  linkage,  or  by  heterogeneity  of  affinity  for  oligosaccharides, 
FIG.  3.  Quantitation of light chain type kappa and lambda gamma globulins  in  isolated 
anti-dextrans from subject 20. The type-specific antiserum is uniformly incorporated in the 
agar plate. The predominance of kappa molecules in the IM6,  and lambda molecules in the 
IM3 and methyl-a-D-glucoside eluates is shown. 
showed variations in kappa:lambda ratios. For example, the IM6 eluates from 
both  subjects  1  and  20  contained predominantly kappa  antibodies;  the IM3 
eluates  were  predominantly  lambda  in  type.  The  variability  of  kappa  and 
lambda  light chain determinants  in  isolated  antibodies  from  subject  20  are 
illustrated in Fig. 3. The methyl-a-D-glucoside eluate from subject 20 contained 
89% lambda-type material; the same eluate from subject J.Ge contained ap- 
proximately 92%  kappa  molecules.  In  subject  R.G.M.,  a-(1  ~  6)-specific 
anti-dextran  consisted  largely  of  kappa  determinants  and  the  subsequent 
a-(1 ~  2)-specific fraction had  somewhat more lambda-type molecules. The 
isolated antibodies to diphtheria and tetanus toxoids showed mixtures of light 
chain determinants in approximately the usual 2:1 ratios found in normal vG- 
immunoglobulin. Isolated antibodies to A substance showed, in one individual, 
a  predominance of kappa  determinants,  and in  the  other a  predominance of 
lambda. 
Gm Typing of Selected Isolated Antibodies.--Some of the isolated antibodies, 
known to be predominantly of the 7G2  heavy chain subgroup,  were studied W. J'. YOUNT, M. M. DORNER, H.  G. KUNKEL, E. A. KABAT  641 
for Gin(n), a genetic antigen recently described, and localized to the Fc portion 
of molecules of the "rG2-subgroup (10). Data from some of the individuals  is 
shown in Table III. The isolated antibodies were successfully typed for Gin(n) 
using either Ouchterlony double diffusion, radial immunoditfusion as described 
above, or the hemagglutination-inhibition system using red blood cells coated 
with  7G2-Gm(n+)  myeloma proteins.  Gin(n+)  antibodies  were  obtained 
TABLE III 
Gm Types of Donor Sera and Isolated Human Antibodies 
Subject 
Gm (type of serum) 
(a)  (g)  (f)  (b)  (n) 
+  +  +  +  + 
20  +  +  + 
J.Ge.  +  +  + 
Fo.  +  +  + 
Antibody  method  of isolation 
Dextran IM6 eluate 
Dextran IM3 eluate 
Levan acid eluate 
Diphtheria toxoid 
antigen excess 
Dextran IM3 eluate 
Dextran IM6 eluate 
Dextran glucose eluate 
Methyl-or  -v-glucoside 
eluate 
Dextran glucose eluate 
DextranBS12 
dextranase eluate 
30  +  +  --  --  --  DextranOP155 
dextranase eltmte 
Gm (type) of antibody (% 
antibody protein)* 
(~  (n) 
--  <1%  -- 
-  <1%  <io% 
-  <0.3%  >85% 
-  <s%  lo-4o% 
<5%  >30% 
<5%  <is% 
<1%  lo-4o% 
<2%  >~% 
<4%  + 
+ 
* Estimated from TG concentration at last inhibiting dilution vs. known sensitivities of 
Gm systems. 
only from individuals positive  for Gm(n)  in whole serum.  The IM6  eluate 
from subject 1 who was known to be  heterozygous for the gene  complexes 
Gm  n+ G~  b Gm  fy and Gm  n- Crmg Gm  ~" was  Gm(n-) whereas  all  other anti- 
dextrans and the anti-levan from this donor were Gm(n+) at the same "yG2- 
protein  concentrations.  The IM6  eluate isolated  from subject 20,  who  was 
known to be homozygous for Gm(0 at the "yGl-locus, and for Gin(b)  at the 
~G3-1ocus and whose serum was Gin(n+) was repeatedly Gin(n-) in the pre- 
cipitin system and only a trace of Gin(n) antigen could be detected by hemag- 
glutination inhibition although within the limits of detection his anti-dextrans 
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tions from the same individual also shown to be ~/G2-subgroup  molecules were 
tested at the same protein concentrations and found to be Gin(n+). This donor 
therefore must have been heterozygous at the q~G2-1ocus and carried both the 
Crm  ~+ Gmb Gm  fy and the Grn  ~- Gmb Gm  fy gene complexes known to exist in 
Caucasians. The same was probably true of subject Fo., another donor whose 
serum was Gin(n+). Isolated o~-(1 --~ 6)-specific anti-dextran from this donor 
contained "rG2-protein, 180 t~g/ml, but failed to inhibit the Gin(n) system. The 
Gin(n)  system as employed for this study was  capable  of detecting Gin(n) 
antigen on ~/G2-molecules at 8/~g/ml. 
DISCUSSION 
The most striking finding in this study was the dominance of ~/G2-subgroup 
molecules in isolated antibodies to dextran, levan, and teichoic acid despite the 
fact that this subgroup makes up only 23 % of normal ~G-globulin. In contrast, 
other  antibodies including anti-A  isoagglutinins, anti-tetanus  toxoid,  anti- 
diphtheria  toxin  consisted  primarily  of  the  major  ~Gl-subgroup.  Anti-Rh 
antibodies which we have studied are also known to consist primarily of the 
major ~/Gl-subgroup. At present no explanation for this selective distribution is 
available. A possible relationship to the carbohydrate nature of these antigens 
might exist, or it may represent a result of the immunization procedure. The 
antibodies to dextran and levan were obtained from individuals who had re- 
ceived two subcutaneous injections a  number of years previously. The anti- 
bodies to teichoic acid probably arose through natural staphylococcal infection. 
Some suggestion of a  relationship to specificity was obtained from the sub- 
fractionation of the dextran antibodies. The dextran antibodies of a-(1 --~ 6) 
specificity in  six  of  eight  donors  were  predominantly  or  exclusively ~,G2- 
subgroup, and in the seventh and eighth donors (Fo. and R.G.M.), ~,G2 ac- 
counted for 50 and 25 %  of antibody protein respectively. The dextran anti- 
bodies of a-(1 --~ 2) specificity were similar in heavy chain composition to those 
of a-(1 -~ 6) specificity with three individuals studied. 
Earlier studies on many of these same antibodies had revealed a number of 
peculiar  features which  could not be  explained  at  that  time  (2).  Analyses 
for the  Gm and Inv genetic markers had  shown a  striking absence  of  Gm 
antigens in a  number of the anti-dextrans as well as in the anti-levan from 
subject 1. These studies were carried out with reagents for Gin(a) and Gm(b). 
Later when Gm(f) became available, the antigen was tested for and also found 
to be missing. Recently it has been recognized (8)  that all of these genetic 
markers are subgroup specific and are not found in the ~,G2-subclass  proteins, 
thus explaining their absence in these isolated antibodies. The newly described 
genetic marker, Gm(n), is the only one available for the -rG2-subclass (10), and 
it was found in a number of the antibodies in the present study. The phenome- 
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demonstrable by fluorescent antibody studies of the products of single  cells 
(29), was apparent in the selective exclusion of Gm~n) in INI6 anti-dextrans of 
subjects 1 and 20 and not in others, although all their anti-dextran subfractions 
consisted primarily of vG2-molecules. 
It  has also been known for a  number  of years that  the anti-dextrans  of 
subject 20  exhibited poor sensitization  of intestine  and  weak PCA  (passive 
cutaneous anaphylaxis)  reactions when tested in guinea pigs (30).  It is now 
known  that  proteins  of  the "#,G2-subclass completely lack  the  capacity for 
skin fixation for PCA reactions (31) in contrast to other "yG-gtobulins, and the 
unusual findings  with the anti-dextran  antibodies are explainable on the basis 
of high vG2 content. 
Analyses for kappa and lambda light chains in the anti-dextrans  that were 
subfractionated were of particular  interest.  The whole anti-dextran  antibody 
preparations prior  to subfractionation contained high concentrations  of both 
kappa  and  lambda  light  chains.  After  subfractionation,  however,  the  IMe 
eluates from two subjects contained a preponderance of kappa chains while the 
IM8 eluates were mainly lambda in type. In most other instances,  however, 
no obvious relationship  was apparent between antigenic specificity and light 
chain  type. The antibody to levan was of  special  interest because it showed 
only kappa  chains  and  no lambda  chains  were detected by procedures  that 
could determine  as little  as  1%  concentration.  It  also was entirely vG2  in 
terms of heavy chain type and inhibited the Gin(n)  system equally as well as 
Gin(n-{-) myeloma proteins and thus was entirely analagous by these  criteria 
to a myeloma protein of the ~,G2-Gm(n+) kappa  type.  This was also one of 
the antibodies that readily produced "individually specific" rabbit antibodies 
(32), another well known characteristic of myeloma proteins. 
Previous  studies  (14)  have  demonstrated  clear  amino  acid  composition 
differences  between a number of the antibodies utilized in the present study. 
Certainly a portion of these relate to kappa and lambda light chain variations 
as  well as  heavy chain  subgroup composition differences.  For  example,  the 
large amino acid differences  between a-(1 --~ 2) and a-(1 ~  6) anti-dextrans 
may well follow the marked difference in kappa:lambda ratios in their light 
chains.  The  amino  acid  composition is  probably less  affected by the heavy 
chain subgroups involved because of the similarity of heavy chain subgroup 
composition in each of three individuals studied and because of marked simi- 
larities between the heavy chain subgroups. Only four tryptic peptide differ- 
ences were observed by fingerprint  analysis when the Fc fragments of ~,G1- 
and vG2-proteins were compared (33). 
The degree of homogeneity observed with these antibodies was progressively 
increased by subfractionation on the basis of antibody specificity for glycosidic 
linkage or combining site size, rather  than by physicochemical fractionation. 
The prevalence of q,  G2-molecules  in the antibodies to dextran  was apparent 644  STUDIES  ON  HUMAN  ANTIBODIES.  VI 
prior  to  such  subfractionation,  but  subfracfionafion  produced  progressive 
homogeneity both for genetic type of heavy chains and  for light chain  type 
as well. The reason for the relatively striking homogeneity in contrast to the 
marked heterogeneity of most antibodies, even to haptenes,  remains obscure. 
Possibly it relates to the carbohydrate nature of the antigen involved, particu- 
larly in view of recent studies showing homogeneous populations of antibodies 
to bacterial polysaccharides which may be elicited in rabbits (34). 
SUMMARY 
The composition of various isolated  antibodies was determined by quanti- 
tative analyses for heavy chain subgroups and light chain types. Certain 
antibodies such as anti-tctanus toxoid and anti-A isoagglutinins were pre- 
dominantly of the major 3,G1-type. However, a high preponderance of mole- 
cules  of the minor q,  G2-subgroup was found for antibodies  to dcxtran, Icvan, 
and teichoic  acid. These findings explain some unusual features previously 
noted for anti-dextrans  such as weak PCA reactions  and lack of Gm  antigens. 
Studies of several  isolatcd  antibodies from single  hctcrozygous  individuals 
showed a selective  absence of genetic markers in certain  antibodies  and their 
presence in others.  The "allclic  exclusion"  principle  was clearly  evident in the 
isolated  antibodies  of two different  individuals. 
Large differences  in the ratio  of kappa to lambda light  chains were observed 
for the same type of antibody from different  individuals.  Subfractionation of 
dextran antibodies  by affinity  for specific  glycosidic  linkage or combining site 
sic produced marked changes in  the ratios.  The isomaltohexaosc eluates  of the 
dextran antibodies  from two subjects  were primarily kappa and the isomalto- 
triose  eluatcs  wcrc predominantly lambda. 
The one anti-levan  antibody studied was uniquely homogeneous, consisting 
exclusively  of 7G2-heavy chains and kappa light  chains.  By these  criteria  as 
well  as others,  it  closely  resembled mycloma proteins. 
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